Lutetium-177Lu-Edotreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177Lu-Edotreotide, covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE [Phase 3]